Application of a scoring system in Japanese patients diagnosed with atypical hemolytic uremic syndrome to assess the relationship between the score and clinical responses to eculizumab

[1]  S. Ito,et al.  Eculizumab for paediatric patients with atypical haemolytic uraemic syndrome: full dataset analysis of post-marketing surveillance in Japan , 2022, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  M. Shimaoka,et al.  The evaluation of a scoring system for diagnosing atypical hemolytic uremic syndrome , 2020 .

[3]  C. Rafat,et al.  Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review , 2020, Toxins.

[4]  D. Landau,et al.  Eculizumab Safety: Five-Year Experience From the Global Atypical Hemolytic Uremic Syndrome Registry , 2019, Kidney international reports.

[5]  A. Cuker,et al.  Clinical and laboratory diagnosis of TTP: an integrated approach. , 2018, Hematology. American Society of Hematology. Education Program.

[6]  R. Go,et al.  Atypical hemolytic uremic syndrome: Review of clinical presentation, diagnosis and management. , 2018, Journal of immunological methods.

[7]  G. Ardissino,et al.  Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome. , 2018, Kidney international.

[8]  M. Nangaku,et al.  Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic–uremic syndrome in Japan: interim analysis of post-marketing surveillance , 2018, Clinical and Experimental Nephrology.

[9]  M. Nangaku,et al.  Safety and effectiveness of eculizumab for adult patients with atypical hemolytic–uremic syndrome in Japan: interim analysis of post-marketing surveillance , 2018, Clinical and Experimental Nephrology.

[10]  Ilker Ünal,et al.  Defining an Optimal Cut-Point Value in ROC Analysis: An Alternative Approach , 2017, Comput. Math. Methods Medicine.

[11]  G. Ardissino,et al.  Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference. , 2017, Kidney international.

[12]  V. Afshar-Kharghan.  Atypical hemolytic uremic syndrome. , 2016, Hematology. American Society of Hematology. Education Program.

[13]  M. Nangaku,et al.  Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis. , 2016, Clinical advances in hematology & oncology : H&O.

[14]  M. Nangaku,et al.  Clinical guides for atypical hemolytic uremic syndrome in Japan , 2016, Clinical and Experimental Nephrology.

[15]  M. Nangaku,et al.  Clinical guides for atypical hemolytic uremic syndrome in Japan , 2016, Pediatrics international : official journal of the Japan Pediatric Society.

[16]  G. Ardissino,et al.  Improved renal recovery in patients with atypical hemolytic uremic syndrome following rapid initiation of eculizumab treatment , 2016, Journal of Nephrology.

[17]  A. Pani,et al.  Diagnosis of complement alternative pathway disorders. , 2016, Kidney international.

[18]  H. Wada,et al.  Natural History of Thrombotic Thrombocytopenic Purpura and Hemolytic Uremic Syndrome , 2014, Seminars in Thrombosis & Hemostasis.

[19]  Lawrence Copelovitch,et al.  Current treatment of atypical hemolytic uremic syndrome. , 2014, Intractable & rare diseases research.

[20]  M. Nangaku,et al.  Diagnostic criteria for atypical hemolytic uremic syndrome proposed by the Joint Committee of the Japanese Society of Nephrology and the Japan Pediatric Society , 2014, Pediatrics international : official journal of the Japan Pediatric Society.

[21]  M. Nangaku,et al.  Diagnostic criteria for atypical hemolytic uremic syndrome proposed by the joint committee of the Japanese society of nephrology and the Japan pediatric society , 2014, Clinical and Experimental Nephrology.

[22]  L. Rostaing,et al.  Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[23]  M. Radhi,et al.  Thrombotic Microangiopathies , 2012, ISRN hematology.

[24]  G. Remuzzi,et al.  Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[25]  P. Bossuyt,et al.  The diagnostic odds ratio: a single indicator of test performance. , 2003, Journal of clinical epidemiology.

[26]  S. D. Subba Rao,et al.  Atypical hemolytic uremic syndrome. , 2002, Indian pediatrics.

[27]  OUP accepted manuscript , 2022, Nephrology Dialysis Transplantation.

[28]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..